Frost & Sullivan

AUGUST 26, 2024

27 th August 2024 – Frost & Sullivan recently assessed the biotech contract research organization (CRO) industry and, based on its results, recognizes Avance Clinical with the 2024 Global Customer Value Leadership Award. SAN ANTONIO, TX. –

Biotech 52

Biotech Contract research organization Partnering capability and readiness Collaboration 52

Frost & Sullivan

AUGUST 29, 2024

This is fueling the growing demand for outsourcing, with contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) driving industry growth. Conversely, small-to-mid, and emerging biopharma players, with 1 or 2 molecules in the pipeline, contribute over 16%.

Biopharma 52

Biopharma Biotechnology Contract research organization Utilities 52

Frost & Sullivan

OCTOBER 11, 2024

San Antonio, TX — 14 th October 2024 — Frost & Sullivan recently conducted an in-depth analysis of the biotech contract research organization (CRO) industry and based on its findings, has awarded Novotech the 2024 Global Company of the Year Award.

Biotech 52

Biotech Contract research organization Strategic partnership Collaboration 52

Jake Jorgovan

JUNE 3, 2024

Additionally, evaluating the firm's approach to communication and collaboration is crucial. Novotech Novotech is a global full-service clinical Contract Research Organization (CRO) specializing in drug development consulting for biotech and pharmaceutical companies. What drug development consulting firm will you choose?

Biopharma 130

Biopharma Biotech Biopharmaceuticals Life science 130

Frost & Sullivan

AUGUST 21, 2024

It also facilitates collaboration between traditionally separate industries, creating new opportunities for growth and innovation. Contract research organizations (CROs) and pharmaceutical companies are using AI to refine their go-to-market strategies, improve patient recruitment, and enhance retention for decentralized trials.

Contract research organization 52

Contract research organization Ecosystems Collaboration 52

Frost & Sullivan

MARCH 22, 2024

Growing demand for outsourcing, with contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) leading industry growth. Top 10 pharma companies contribute only 4-5% to R&D pipeline; top 25 contribute less than 10%.

Ecosystems 52

Ecosystems Biopharma Biotech Contract research organization 52

Frost & Sullivan

FEBRUARY 15, 2024

Let us coach you on your transformational journey, while we actively support you in fostering collaborative initiatives within your industry’s ecosystem. Small- to mid-sized pharma/biotech players in APAC are rivaling Europe in clinical trials through multiple CRO partnerships in the region, tapping into a population-rich landscape.

Ecosystems 40

Ecosystems Contract research organization Biotech Utilities 40